Video

Finding Emotional Support in a Health Care Team

The winner of the CURE® Extraordinary Healer® Award for Oncology Nursing discussed the bonds formed between patients with cancer and their health care team.

Caitlin Cohen, M.S.N., RN, CPNP-AC, CPHON, winner of the CURE® Extraordinary Healer® Award for Oncology Nursing, discussed how being an oncology nurse is like being “part of the family.” When you’re providing oncology care, especially to a young patient, the family looks to you for guidance, medical advice and emotional support, said Cohen.

“I think that when you become a part of the treatment team for a patient, or a young child or an older child, with oncology diseases, you become a part of their family,” said Cohen.

“We were there to provide (patients) with emotional support and let them know that we still always thought about them. We never stop thinking about the patients that we’ve cared for. We are always there if they need to reach out for anything and we will do everything in our power when we can to help.”

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of man with text.
An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.
After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked her emotional recovery.
Terry Gillespie said the hardest parts of her cancer journey were the isolation, the impact of chemotherapy, and how unprepared she felt despite good guidance.
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Outpatient CAR T-cell therapy has reduced hospital stays by two-thirds while maintaining safety for those with blood cancers, according to Dr. Olalekan Oluwole.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
Related Content